CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Grant or award Director acquired 3,516 shares (grant or award)
- 4 Grant or award Director acquired 4,298 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 26,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief People Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 26,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 81,600 shares (grant or award)
- 4 Open-market buy Director bought 5,667 shares at $5.60 ($31,735)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,301 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,301 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,222 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 4,319 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 1,301 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,301 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,301 shares (to pay taxes)
- 4 Option exercise Director acquired 712 shares (option exercise)
- 4 Grant or award Director acquired 1,568 shares (grant or award)
- 4 Grant or award Director acquired 1,763 shares (grant or award)
- 4 Grant or award Director acquired 1,725 shares (grant or award)
Page 8 of 15 · 296 filings